menu toggle

Bexacat™

(bexagliflozin tablets)

A different way to treat feline diabetes

Bexacat logo with black and white cat

About Bexacat

The search for a non-insulin alternative is over

Bexacat tablets bottle and box
Bexacat tablets bottle and box

Bexacat™ is the FIRST non-insulin oral treatment specifically designed for feline diabetes in otherwise healthy cats not previously treated with insulin.

  • Breakthrough SGLT2 inhibitor - Innovative sodium-glucose cotransporter 2 (SGLT2) inhibitor provides effective glycemic control without injections
  • Effective glycemic control - Decreases average blood glucose concentration by over 70% in just 8 hours1 with minimal risk of hypoglycemia
  • One tablet. Once a day. - Convenient, needle-free, once-daily tablet dosed independently of patient weight ensures dosing accuracy*
Bexacat tablets bottle and box

How Bexacat works

Bexacat is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. SGLT2 is the primary transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation.

  • By inhibiting SGLT2, Bexacat reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, increasing urinary glucose excretion.
  • This increase in glucose excretion through the urine, in turn, lowers the plasma glucose concentration in the blood.

Backed by efficacy

Treatment success

In a series of multicenter field studies, Bexacat was proven to be effective at improving glycemic control in cats.
83.1%
of cats were considered treatment successes at day 56*
>85%
of cats were considered treatment successes at day 728**

Percentage of cats with improvements in clinical signs by Day 56*

  • 68.0% cats improved in polyuria
  • 74.0% cats improved in polydipsia
  • 57.1% cats improved in polyphagia
  • 54.6% cats improved in body weight
 *In a 180-day multicenter field effectiveness and safety study.
**In an extended use study of cats previously treated with bexagliflozin.
Bexacat 30 count tablets bottle and packaging

Product highlights

  • Provides effective glycemic control without injections
  • Minimal risk of hypoglycemia and no dosage changes during treatment5
  • Convenient, needle-free, once-daily flavored tablet dosed independently of patient weight ensures dosing certainty.*
  •  No dose titration needed
  • Can be given with food for convenient administration
  • No refrigeration required
References
*Approved for cats weighing 6.6 lbs. (3.0 kg) or greater.
1Elanco Animal Health. Data on file.
5Bexacat Freedom of Information Summary, NADA 141-566.

The convenient, once-daily alternative to insulin is here

Prescribe effective glycemic control with an orally administered SGLT2 inhibitor.
Black and white cat